Assessment of associations between neutrophil extracellular trap biomarkers in blood and thrombi in acute ischemic stroke patients

Tristan Baumann,Nicole de Buhr,Nicole Blume,Maria M. Gabriel,Johanna Ernst,Leonie Fingerhut,Rabea Imker,Omar Abu-Fares,Mark Kühnel,Danny D. Jonigk,Friedrich Götz,Christine Falk,Karin Weissenborn,Gerrit M. Grosse,Ramona Schuppner

DOI: https://doi.org/10.1007/s11239-024-03004-y

2024-06-11

Journal of Thrombosis and Thrombolysis

Abstract:Inflammation including immunothrombosis by neutrophil extracellular traps (NETs) has important implications in acute ischemic stroke and can affect reperfusion status, susceptibility to stroke associated infections (SAI) as well as functional clinical outcome. NETs were shown to be prevalent in stroke thrombi and NET associated markers were found in stroke patients' blood. However, little is known whether blood derived NET markers reflect the amount of NETs in thrombi. Conclusions from blood derived markers to thrombus composition might open avenues for novel strategies in diagnostic and therapeutic approaches. We prospectively recruited 166 patients with acute ischemic stroke undergoing mechanical thrombectomy between March 2018 and May 2021. Available thrombi (n = 106) were stained for NET markers DNA-histone-1 complexes and myeloperoxidase (MPO). Cell free DNA (cfDNA), deoxyribonuclease (DNase) activity, MPO-histone complexes and a cytokine-panel were measured before thrombectomy and after seven days. Clinical data, including stroke etiology, reperfusion status, SAI and functional outcome after rehabilitation, were collected of all patients. NET markers were present in all thrombi. At onset the median concentration of cfDNA in blood was 0.19 μg/ml increasing to 0.30 μg/ml at 7 days. Median DNase activity at onset was 4.33 pmol/min/ml increasing to 4.96 pmol/min/ml at 7 days. Within thrombi DNA-histone-1 complexes and MPO correlated with each other ( ρ = 0.792; p < 0.001). Moreover, our study provides evidence for an association between the amount of NETs and endogenous DNase activity in blood with amounts of NETs in cerebral thrombi. However, these associations need to be confirmed in larger cohorts, to investigate the potential clinical implications for individualized therapeutic and diagnostic approaches in acute ischemic stroke.

cardiac & cardiovascular systems,peripheral vascular disease,hematology

What problem does this paper attempt to address?

### What problems does this paper attempt to solve?

This paper aims to explore the association of neutrophil extracellular traps (NETs) in the blood and thrombus of patients with acute ischemic stroke. Specifically, the main research questions include:

1. **Can NETs blood markers reflect the NETs content in cerebral thrombus?**
- Researchers hope to understand whether NETs - related markers in the blood (such as free DNA, deoxyribonuclease activity, MPO - histone complexes, etc.) can be used as surrogate markers for the NETs content in cerebral thrombus. This is helpful for developing new diagnostic and treatment strategies.

2. **The role of NETs in acute ischemic stroke**
- The study explored the role of NETs in the inflammatory response in patients with acute ischemic stroke, especially the impact of NETs during mechanical thrombectomy (MT). NETs have been proven to be related to the reperfusion state, stroke - associated infections (SAI), and functional clinical outcomes.

3. **The relationship between NETs markers and clinical outcomes**
- The study also evaluated the association between NETs markers and patient clinical outcome parameters (such as recanalization, SAI, functional outcome, and etiology). In addition, researchers analyzed a series of cytokines to confirm the previously discovered correlation between NETs markers and cytokines and to explore the possible connection between NETs and the systemic cytokine response.

### Research background

The inflammatory mechanism is an important part of the pathophysiology of ischemic stroke, among which immuno - thrombosis is particularly important. NETs are a structure released by neutrophils that can capture and kill microorganisms, but also promote platelet aggregation, thus affecting the course and treatment effect of stroke. Although previous studies have shown that NETs exist in the cerebral thrombus of stroke patients, little is known about whether NETs markers in the blood can reflect the NETs content in the cerebral thrombus.

Through this study, researchers hope to find the potential association between blood markers and the composition of cerebral thrombus, thus providing new ideas for personalized diagnosis and treatment of acute ischemic stroke.